BioGaia AB Series B | Key People and Executives
Peter Rothschild
Chairman
Isabelle Valerie G. Ducellier
Director
Peter Axel Gunnar Elving
Director
David E. R. Dangoor
Vice Chairman
Anthon Jahreskog
Independent Director
Brit Stakston
Independent Director
Inger Holmström
Independent Director
Peter Rothschild
Chairman
Sebastian Schröder
Managing Director
Katayoun Welin-Berger
Vice President-Operations
Margareta Hagman
EVP-Accounting, Finance & Investor Relations
Kristina Magnusson Borg
Vice President-Discovery & Research
Jakob Axelsson
Research Manager
Isabelle Valerie G. Ducellier
Director
Peter Axel Gunnar Elving
Director
Urban Strindlöv
Executive Vice President & Director-Sales
Ulrika Köhler
Vice President-Marketing & Product Development
Helen Olsson
Vice President-Human Resources
Marika Isberg
General Counsel
David E. R. Dangoor
Vice Chairman
Anthon Jahreskog
Independent Director
Brit Stakston
Independent Director
Inger Holmström
Independent Director
| Address |
Kungsbroplan 3
Stockholm AB 112 27
Sweden
|
|
Employees
|
- |
| Website |
http://www.biogaia.com |
| Updated |
07/08/2019 |
| BioGaia AB engages in the development, marketing, and sale of probiotic products. It operates through the following segments: Pediatrics, Adult Health, and Other. The Pediatrics segment is comprised of sales of drops, oral rehydration solutions (ORS), digestive health tablets and also cultures as an ingredient in a licensee's products, as well as royalties pertaining to pediatric products. |
